Interferon-gamma-mediated hepatocarcinogenesis in mice treated with diethylnitrosamine (Q46375786)

21 December 2017

title

Interferon-gamma-mediated hepatocarcinogenesis in mice treated with diethylnitrosamine (English)

1 reference

21 December 2017

author name string

Mitsuru Matsuda

1

1 reference

21 December 2017

Yasunari Nakamoto

2

1 reference

21 December 2017

Satoshi Suzuki

3

1 reference

21 December 2017

Tomomitsu Kurata

4

1 reference

21 December 2017

Shuichi Kaneko

5

1 reference

21 December 2017

publication date

1 May 2005

1 reference

21 December 2017

published in

Laboratory Investigation

1 reference

21 December 2017

volume

85

1 reference

21 December 2017

issue

5

1 reference

21 December 2017

page(s)

655-663

1 reference

21 December 2017

https://scigraph.springernature.com/pub.10.1038/labinvest.3700257

exact match

0 references

cites work

Hepatocellular carcinoma: Recent progress

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700257

Interspecies comparison of liver carcinogenesis: implications for cancer risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700257

Immune pathogenesis of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700257

Prevention of hepatocellular carcinoma development associated with chronic hepatitis by anti-fas ligand antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700257

N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700257

Expression of p53 mutant protein(s) in diethylnitrosamine-induced foci of enzyme-altered hepatocytes in male Fischer-344 rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700257

Macrophage and hepatic stellate cell responses during experimental hepatocarcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700257

Immunohistochemical localization of inducible nitric oxide synthase and 3-nitrotyrosine in rat liver tumors induced by N-nitrosodiethylamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700257

Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700257

Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700257

Interferon gamma induces differential upregulation of alpha and beta chemokine secretion in colonic epithelial cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700257

Mutagenesis associated with nitric oxide production in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700257

Hepatocellular carcinoma in Italian patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700257

inferred from DOI database lookup

7 January 2021

based on heuristic

Risk factors for hepatocellular carcinoma among patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700257

inferred from DOI database lookup

7 January 2021

based on heuristic

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700257

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LABINVEST.3700257

1 reference

21 December 2017

1 reference

21 December 2017